Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 12;40(9):999-1009.e6.
doi: 10.1016/j.ccell.2022.08.006. Epub 2022 Sep 1.

Detection and localization of early- and late-stage cancers using platelet RNA

Sjors G J G In 't Veld  1 Mohammad Arkani  2 Edward Post  3 Mafalda Antunes-Ferreira  3 Silvia D'Ambrosi  3 Daan C L Vessies  4 Lisa Vermunt  5 Adrienne Vancura  3 Mirte Muller  6 Anna-Larissa N Niemeijer  7 Jihane Tannous  8 Laura L Meijer  9 Tessa Y S Le Large  9 Giulia Mantini  10 Niels E Wondergem  11 Kimberley M Heinhuis  12 Sandra van Wilpe  13 A Josien Smits  7 Esther E E Drees  14 Eva Roos  15 Cyra E Leurs  16 Lee-Ann Tjon Kon Fat  17 Ewoud J van der Lelij  3 Govert Dwarshuis  3 Maarten J Kamphuis  3 Lisanne E Visser  3 Romee Harting  3 Annemijn Gregory  3 Markus W Schweiger  18 Laurine E Wedekind  3 Jip Ramaker  3 Kenn Zwaan  3 Heleen Verschueren  3 Idris Bahce  7 Adrianus J de Langen  6 Egbert F Smit  6 Michel M van den Heuvel  19 Koen J Hartemink  20 Marijke J E Kuijpers  21 Mirjam G A Oude Egbrink  22 Arjan W Griffioen  10 Rafael Rossel  23 T Jeroen N Hiltermann  24 Elizabeth Lee-Lewandrowski  25 Kent B Lewandrowski  25 Philip C De Witt Hamer  3 Mathilde Kouwenhoven  26 Jaap C Reijneveld  27 William P J Leenders  28 Ann Hoeben  29 Irma M Verdonck-de Leeuw  30 C René Leemans  31 Robert J Baatenburg de Jong  32 Chris H J Terhaard  33 Robert P Takes  34 Johannes A Langendijk  35 Saskia C de Jager  36 Adriaan O Kraaijeveld  37 Gerard Pasterkamp  36 Minke Smits  13 Jack A Schalken  38 Sylwia Łapińska-Szumczyk  39 Anna Łojkowska  39 Anna J Żaczek  40 Henk Lokhorst  41 Niels W C J van de Donk  41 Inger Nijhof  41 Henk-Jan Prins  41 Josée M Zijlstra  41 Sander Idema  3 Johannes C Baayen  3 Charlotte E Teunissen  5 Joep Killestein  16 Marc G Besselink  15 Lindsay Brammen  42 Thomas Bachleitner-Hofmann  43 Farrah Mateen  44 John T M Plukker  45 Michal Heger  46 Quirijn de Mast  47 Ton Lisman  48 D Michiel Pegtel  14 Harm-Jan Bogaard  7 Jacek Jassem  49 Anna Supernat  40 Niven Mehra  13 Winald Gerritsen  13 Cornelis D de Kroon  50 Christianne A R Lok  51 Jurgen M J Piek  52 Neeltje Steeghs  12 Winan J van Houdt  53 Ruud H Brakenhoff  11 Gabe S Sonke  54 Henk M Verheul  13 Elisa Giovannetti  55 Geert Kazemier  9 Siamack Sabrkhany  56 Ed Schuuring  57 Erik A Sistermans  58 Rob Wolthuis  59 Hanne Meijers-Heijboer  59 Josephine Dorsman  59 Cees Oudejans  60 Bauke Ylstra  14 Bart A Westerman  3 Daan van den Broek  4 Danijela Koppers-Lalic  3 Pieter Wesseling  61 R Jonas A Nilsson  17 W Peter Vandertop  3 David P Noske  3 Bakhos A Tannous  8 Nik Sol  26 Myron G Best  62 Thomas Wurdinger  63
Affiliations
Free article

Detection and localization of early- and late-stage cancers using platelet RNA

Sjors G J G In 't Veld et al. Cancer Cell. .
Free article

Abstract

Cancer patients benefit from early tumor detection since treatment outcomes are more favorable for less advanced cancers. Platelets are involved in cancer progression and are considered a promising biosource for cancer detection, as they alter their RNA content upon local and systemic cues. We show that tumor-educated platelet (TEP) RNA-based blood tests enable the detection of 18 cancer types. With 99% specificity in asymptomatic controls, thromboSeq correctly detected the presence of cancer in two-thirds of 1,096 blood samples from stage I-IV cancer patients and in half of 352 stage I-III tumors. Symptomatic controls, including inflammatory and cardiovascular diseases, and benign tumors had increased false-positive test results with an average specificity of 78%. Moreover, thromboSeq determined the tumor site of origin in five different tumor types correctly in over 80% of the cancer patients. These results highlight the potential properties of TEP-derived RNA panels to supplement current approaches for blood-based cancer screening.

Keywords: RNA; TEP; blood; blood platelets; cancer; early detection; liquid biopsy.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests M.G. Best, R.J.A.N., and T.W. are inventors on relevant patent applications (PCT/NL2011/050518 and PCT/NL2018/050110). R.J.A.N. and T.W. are shareholders of Illumina, Inc. M.H. is chief formulation officer at Nurish.Me, Inc., and Camelina Sun LLC and has equity in those companies (whose business activities are unrelated to the present work). D.M.P. and D.K.L. are shareholders of ExBiome BV.

Comment in

Similar articles

Cited by

Publication types